“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways 23, no. 1 (February 7, 2022). Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1510.